Electrical Nerve Block for Amputation Pain
Status: | Recruiting |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 6/3/2018 |
Start Date: | October 9, 2014 |
End Date: | September 2025 |
Contact: | Barbara S Lindsay |
Email: | blindsay@neurosmedical.com |
High-Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study
The purpose of the clinical trial is to learn whether electrical nerve block via the Altius
System is a safe and effective treatment for patients with post-amputation pain.
System is a safe and effective treatment for patients with post-amputation pain.
The Altius System is an implanted device designed to electrically block nerve signals and
alleviate pain. Use of this device may be associated with providing an effective,
mechanism-based yet non-destructive, treatment for managing intractable limb pain in
amputees. In a given patient, the Altius System will be deemed effective if treatment results
in 50% reduction of pain score for more than 50% of all pain episodes.
alleviate pain. Use of this device may be associated with providing an effective,
mechanism-based yet non-destructive, treatment for managing intractable limb pain in
amputees. In a given patient, the Altius System will be deemed effective if treatment results
in 50% reduction of pain score for more than 50% of all pain episodes.
Key Inclusion Criteria:
- Age ≥ 21 years old
- Unilateral amputated leg ≥ 12 months
- Chronic post amputation pain ≥ 6 months
- Pain episodes typically lasting ≥ 60 minutes
- Stable drug regimen ≥ 6 weeks
- No changes to medications or prosthesis for 3-month primary study period
Key Exclusion Criteria:
- Implanted with an active implantable medical device (i.e. pacemaker)
- Confounding source of pain that interferes with reporting of limb pain
- Uncontrolled diabetes
- Spasticity preventing full range of motion of involved side
- Extremely short stump; sits on end
- Untreated psychological condition (i.e. borderline personality)
- Condition requiring MRI studies or diathermy after device implant
- Life expectance of less than 24 months
- Progressive neurological disease (i.e. multiple sclerosis)
We found this trial at
13
sites
New York, New York 10022
Principal Investigator: Cory Hunter, MD
Phone: 212-203-2813
Click here to add this to my saved trials
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
2035 W Taylor St
Chicago, Illinois
Chicago, Illinois
(312) 996-4350
Principal Investigator: Konstantin Slavin, MD
Phone: 312-996-2949
University of Illinois at Chicago A major research university in the heart of one of...
Click here to add this to my saved trials
Cleveland, Ohio 44195
Principal Investigator: Nagy Mekhail, MD
Phone: 216-445-8270
Click here to add this to my saved trials
Cleveland, Ohio 44106
Principal Investigator: Elias Veizi, MD
Phone: 216-791-3800
Click here to add this to my saved trials
Click here to add this to my saved trials
Little Rock, Arkansas 72205
Principal Investigator: Erika Petersen, MD
Phone: 501-526-5282
Click here to add this to my saved trials
Napa, California 94558
Principal Investigator: Eric Grigsby, MD
Phone: 707-252-9606
Click here to add this to my saved trials
Rancho Mirage, California 92270
Principal Investigator: Tobias Moeller-Bertram, MD
Phone: 760-994-7441
Click here to add this to my saved trials
Scottsdale, Arizona 85258
Principal Investigator: Tory McJunkin, MD
Phone: 480-245-6138
Click here to add this to my saved trials
Springboro, Ohio 45066
Principal Investigator: Vivek A. Manocha, MD
Phone: 937-395-8367
Click here to add this to my saved trials
245 Village Center Parkway
Stockbridge, Georgia 30281
Stockbridge, Georgia 30281
Principal Investigator: Vincent Galan, MD
Phone: 770-771-6577
Click here to add this to my saved trials
Winston-Salem, North Carolina 27103
Principal Investigator: Leonardo Kapural, MD
Phone: 336-765-6181
Click here to add this to my saved trials